Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mitochondrial genetic polymorphisms and pancreatic cancer risk.

Mitochondrial genetic polymorphisms and pancreatic cancer risk. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mitochondrial genetic polymorphisms and pancreatic cancer risk. Abstract Text:

    liang wangLiang Wang,william r bamletWilliam R Bamlet,mariza de andradeMariza de Andrade,lisa a boardmanLisa A Boardman,julie m cunninghamJulie M Cunningham,stephen n thibodeauStephen N Thibodeau,gloria m petersenGloria M Petersen,

    The role of genes that influence the risk of developing pancreatic cancer (PC) has not been well studied. The mitochondrion, conventionally thought to be an organelle specific to energy metabolism, is in fact multifunctional and has been implicated in many diseases, including cancer. To evaluate whether single nucleotide polymorphisms in mitochondrial DNA (mtSNP) are associated with increased risk of PC, we screened Caucasian cases diagnosed or seen at the Mayo Clinic with primary pancreatic adenocarcinoma (n = 955), and healthy clinic-based Caucasian controls (n = 1,102). A total of 24 mtSNPs, including 10 of the most common tagSNPs, 7 non-tagSNPs in the coding region, and 7 common SNPs in the regulatory region were genotyped. For analysis, these samples were grouped into two phases, the "testing" set (474 cases and 615 controls), and the "validation" set (481 cases and 487 controls). In the testing set, one mtSNP (SNP11719) suggested an association in single SNP analysis, with an odds ratio of 1.34 (95% confidence intervals, 1.05-1.72; P = 0.020), but did not remain statistically significant after correction for multiple testing. In the validation set, none of the 24 variants indicated any association with PC. For haplogroup analysis, 10 core SNPs that form common haplogroups in Caucasians (1719, 4580, 7028, 8251, 9055, 10398, 12308, 13368, 13708, and 16391) were evaluated. No significant associations with PC were identified either by analyzing the two sets separately or combined (combined global P = 0.17). Overall, these results do not support a significant involvement of mitochondrial DNA variation in the risk of developing PC. Investigation of other mitochondrial genetic variations (i.e., nuclear-encoded mitochondrial proteins) would be necessary to elucidate any role of mitochondrial DNA variation in PC.

    Mitochondrial genetic polymorphisms and pancreatic cancer risk. Publishing Authors By Initials

    l wangL Wang,wr bamletWR Bamlet,m de andradeM de Andrade,la boardmanLA Boardman,jm cunninghamJM Cunningham,sn thibodeauSN Thibodeau,gm petersenGM Petersen,

    For similar genetic phenomena: variation (genetics) research abstracts see: genetic phenomena: variation (genetics) research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mitochondrial genetic polymorphisms and pancreatic cancer risk. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Cancer epidemiology, biomarkers & prevention : a p

    VOLUME: 16

    Page Numbers: 1455-9

    Journal Abbreviation: Cancer Epidemiol. Biomarkers P

    ISSN: 1055-9965

    DAY: 3

    MONTH: Jul

    YEAR: 2007

    Mitochondrial genetic polymorphisms and pancreatic cancer risk. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9200608

    Mitochondrial genetic polymorphisms and pancreatic cancer risk. Keywords Mesh Terms:

    KEYWORDS: Variation (Genetics)

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Mitochondrial genetic polymorphisms and pancreatic cancer risk. Information

    Substance Name: Genetic Markers

    Registry Number: 0

    Grant and Affiliation Information for Mitochondrial genetic polymorphisms and pancreatic cancer risk.

    AFFILIATION: Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street Southwest, Stabile 241, Rochester, MN 55905, USA. wang.liang@mayo.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: P50 CA102701

    ACRONYM: CA

    MEDLINETA: Cancer Epidemiol Biomarkers Pr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mitochondrial genetic polymorphisms and pancreatic cancer risk Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News